AT1.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 30, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Atomo Diagnostics Ltd (AT1.AX)

Based on 7 analysts giving stock ratings to Atomo Diagnostics Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
0
Buy
0
Hold
43
Sell
43
Strong Sell
14
Atomo Diagnostics Ltd

Atomo Diagnostics Ltd. Stock Analysis AT1.AX

Australia Health Care Nano Cap Report:
Atomo Diagnostics Ltd. engages in manufacture, research, development, and design of in-vitro medical devices for blood-based rapid diagnostic testing (RDT) for professional use and self-testing. The firm supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The firm has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiations as well as the early detection of pregnancy. Its products include Atomo HIV Self-Test, AtomoRapid Pascal and AtomoRapid Curie, among others. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. The AtomoRapid Pascal platform offers improved performance and usability in point of care testing.
Read More

Atomo Diagnostics Ltd (AT1.AX) Chart

Key Statistics of Atomo Diagnostics Ltd (AT1.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.02AUD0.02

Today's Open

AUD0.02

Volume

288.15K

P/E Ratio (TTM)

-

52 Week Range

AUD0.01AUD0.05

Market Cap

21.63M

Avg. Volume

934.00K

Dividend Yield

-

Financial Metrics & Statements of Atomo Diagnostics Ltd (AT1.AX)

FAQ's for Atomo Diagnostics Ltd (AT1.AX)

  • According to Musaffa’s Shariah screening methodology, Atomo Diagnostics Ltd (AT1.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.